• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION 213, LLC 0113 CHLORAPREP ONE STEP HI LITE ORANGE; 2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION 213, LLC 0113 CHLORAPREP ONE STEP HI LITE ORANGE; 2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL Back to Search Results
Catalog Number 930415NSB
Device Problem Device Markings/Labelling Problem (2911)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/24/2021
Event Type  malfunction  
Manufacturer Narrative
Imdrf annex e code health effect: (b)(4).Initial emdr submission.A follow up emdr will be submitted if additional information becomes available.
 
Event Description
Material no: 930415nsb batch no: 1082946.¿ it was reported that print was illegible.¿ verbatim: "on (b)(6) 2021, during final product inspection of finished good (b)(4), batch# 0061780657, quality control inspector, identified tinted cloraprep ((b)(6)) to have illegible print."label print illegible" is a major visual defect per incoming specification, (b)(4) version: (b)(4).This issue was determined to be a supplier related issue on (b)(6) 2021.This issue involves a single batch of materials: item a7509017, bbmi batch 0061791268 (vendor batch 1082946).".
 
Manufacturer Narrative
The batch record for pn 930415nsb, ln 1082946 was reviewed and there were no defects found during routine in-process inspections related to "illegible print".It is possible that before the printer was cleaned, some applicators with incomplete printing may have gone undetected by production and made it to the finished product bin.This is the first customer complaint received for illegible print for this product line in the last two years.There is no negative trend observed.A corrective action was implemented at the machine at the time of occurrence, no further actions are necessary at this point.Will continue to track and trend for this defect.H3 other text : see narrative section.
 
Event Description
Material no: 930415nsb, batch no: 1082946.  it was reported that print was illegible.  verbatim: "on 08/24/2021, during final product inspection of finished good 332103, batch# 0061780657, quality control inspector, identified tinted cloraprep (a7509017) to have illegible print."label print illegible" is a major visual defect per incoming specification, spec-md-2003980 version: 5.0.This issue was determined to be a supplier related issue on 8/31/2021.This issue involves a single batch of materials: item a7509017, bbmi batch 0061791268 (vendor batch 1082946).".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CHLORAPREP ONE STEP HI LITE ORANGE
Type of Device
2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL
Manufacturer (Section D)
CAREFUSION 213, LLC 0113
1550 northwestern dr
el paso TX 79912
MDR Report Key12475280
MDR Text Key271512395
Report Number3004932373-2021-00431
Device Sequence Number1
Product Code KXF
Combination Product (y/n)Y
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,other
Type of Report Initial,Followup
Report Date 10/06/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2024
Device Catalogue Number930415NSB
Device Lot Number1082946
Initial Date Manufacturer Received 09/02/2021
Initial Date FDA Received09/15/2021
Supplement Dates Manufacturer Received10/06/2021
Supplement Dates FDA Received10/06/2021
Patient Sequence Number1
Patient Outcome(s) Other;
-
-